The effect of loss of Egr1 in CML could reflect its established functions in normal hematopoiesis, maintaining quiescence of HSCs and driving terminal differentiation to the monocyte/macrophage lineage. Here, EGR1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.